Trials / Completed
CompletedNCT00654290
Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft
Effect of Prophylaxy of Amiodarone and Propranolol and Amiodarone With Propranolol in Prevention of Atrial Fibrillation Post Coronary Artery Bypass Graft, A Prospective Double-Blind Randomized Study
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (actual)
- Sponsor
- Shiraz University of Medical Sciences · Academic / Other
- Sex
- All
- Age
- 45 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Atrial fibrillation is the most common arrhythmia post coronary bypass surgery, currently B-blockers are the class I indication to prevent AF post CABG. We decide to evaluate use of propranolol and amiodarone separately and together to find a better prophylaxis for AF peri-CABG
Detailed description
In this double blind randomized study 240 consecutive patients underwent elective coronary artery bypass grafting, being randomized prospectively into three groups, propranolol (p) (n=80), amiodarone (A) (n=80) and amiodarone with propranolol (AP) (n=80). All groups received their medications from 7 days preoperatively and continued their medications for 5 days post CABG.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Amiodarone + Propranolol | Amiodarone and Propranolol 7 days pre-operation to 5 days post CABG |
| DRUG | Amiodarone | Amiodarone treated 7 days pre-operation to 5 days post CABG |
| DRUG | Propranolol | Propranolol from 7 days pre-operation to 5 days post CABG |
Timeline
- Start date
- 2007-03-01
- Primary completion
- 2008-01-01
- Completion
- 2008-02-01
- First posted
- 2008-04-07
- Last updated
- 2008-04-07
Locations
1 site across 1 country: Iran
Source: ClinicalTrials.gov record NCT00654290. Inclusion in this directory is not an endorsement.